Managing Cancer Metabolically: Dr. Donese Worden with Dr. Thomas Seyfried
Dr. Thomas Seyfried YouTube Channel
In this in-depth conversation, physician and metabolic oncology researcher Dr. Donese Worden joins Professor Thomas Seyfried to discuss the most important scientific findings and clinical strategies for managing cancer through metabolic approaches.
The Future of Metabolic Oncology
Dr. Worden and Professor Seyfried begin by discussing the growing need for broader education and clinical implementation in the field of metabolic oncology, including the launch of a new nonprofit organization designed to help advance research, education, and patient access.
Foundations of Metabolic Therapy
The conversation explores the foundational principles behind metabolic cancer therapy, including the role of nutrition, ketosis, glucose regulation, and metabolic flexibility in supporting cellular health.
Special attention is given to the Glucose Ketone Index (GKI), nutritional ketosis, and why metabolic consistency is important when implementing ketogenic metabolic strategies.
Clinical Application of Metabolic Oncology
Dr. Worden and Professor Seyfried discuss how clinicians can translate scientific research into practical treatment applications and what patients should look for when seeking qualified metabolic oncology providers.
The Importance of Stress Management
One often overlooked aspect of metabolic therapy discussed in the interview is the role of stress reduction. Chronic stress can significantly affect blood glucose regulation and may influence a patient’s ability to maintain an optimal metabolic state.
In This Interview You'll Learn
- Why a new metabolic oncology nonprofit is being formed
- How to choose a clinician knowledgeable in metabolic oncology
- The scientific foundations of metabolic cancer therapy
- How the Glucose Ketone Index (GKI) is used in metabolic protocols
- Why stress management is critical for metabolic success
- How patients can better understand nutritional ketosis and metabolic flexibility
Watch the full interview above to hear Dr. Donese Worden and Professor Thomas Seyfried discuss the science, strategy, and future of metabolic oncology.
